Fulvestrant
Neratinib Shows Promise in Certain Metastatic Breast Cancer Cases
A combination of neratinib, fulvestrant and trastuzumab showed encouraging clinical activity in patients with ...
MARCH 9, 2022
Everolimus Ups PFS in Pts With Postmenopausal HR+ Breast Ca
Adding everolimus to fulvestrant improved progression-free survival (PFS) in postmenopausal women with hormone ...
FEBRUARY 10, 2017
Fulvestrant Over Anastrozole for Advanced Breast Cancer
As first-line single-agent hormone therapy, fulvestrant provides more durable disease control than anastrozole in ...
FEBRUARY 8, 2017
SABCS 2016: Everolimus Added to Fulvestrant Upped PFS in Postmenopausal HR+ Breast Ca Pts
San Antonio—Adding everolimus to fulvestrant in postmenopausal women with hormone receptor ...
DECEMBER 8, 2016
Load more